Abstract
Drug delivery is one of the most dynamic and fast growing sectors of the
pharmaceutical industry; the high level of innovation in this sector is
evolving at a fast pace with products such as Pfizer' s inhaled insulin,
Exubera, gaining US approval in January 2006. ' Innovation in Drug Delivery'
provides an in-depth examination of product launches and pipeline drugs with
novel drug delivery mechanisms set to revolutionize the market, such as
products using ALZA Corporation' s E-TRANS and Altea' s PassPort patch
transdermal technologies. This report will enable you to evaluate key marketed
drugs, including Emend and Megace, and gain an insight into novel pipeline
products to anticipate upcoming product launches and position yourself for
success. Use this report to understand how nanotechnology and other key
technologies are changing drug delivery and how these can be implemented into
your R&D process. Assess the impact of innovation in therapy areas including
oncology, diabetes and infectious diseases and identify future opportunities
for market growth.
| 
View Cart
